Analystreport

Myovant Sciences Ltd (NYSE: MYOV) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $8.50 price target on the stock.

Myovant Sciences Ltd. Common Shares  (MYOV) 
Last myovant sciences ltd. common shares earnings: 2/10 08:30 am Check Earnings Report
US:NYSE Investor Relations: investors.myovant.com